Will Genomic Testing Tell Me If I Need the Red Devil?

Here’s something many women don’t realize until they’re deep in the decision:

You may not have to guess whether you need chemotherapy.

There’s a test for that — or close to it. And understanding it can change how you face this entire conversation.

Dr. Singh explains how it works.

A Test That Helps Decide

When you’re newly diagnosed, one of the hardest questions is whether chemotherapy is truly necessary. Genomic testing helps answer it.

As Cynthia raised in the discussion, this kind of testing can help determine whether chemo is needed — and Dr. Singh confirmed it directly.

“If you’re high-risk on the genomic testing — whether it’s Oncotype or MammaPrint — those people would benefit from chemotherapy,” he says. “And that chemotherapy we’re talking about would include the Red Devil.”

In other words, this isn’t a coin flip. For many women, a test on the tumor itself helps guide whether the Red Devil belongs in their plan at all.

What Genomic Testing Actually Looks At

It’s worth clearing up a common mix-up, because the names sound alike.

Genomic testing doesn’t look at the genes you inherited. It looks at the tumor — examining the activity of specific genes inside the cancer to predict how it’s likely to behave, and how likely it is to come back.

Tests like Oncotype DX and MammaPrint turn that information into a risk picture. A lower-risk result may mean chemotherapy adds little benefit. A higher-risk result suggests chemo — potentially including the Red Devil — could meaningfully lower the chance of recurrence.

You can learn more about how this works on your own tumor in our genomic testing guide.

Why This Matters So Much

Sit with what this means for a moment.

For some women, genomic testing is the difference between needing the Red Devil and being able to safely skip it. It can spare people the side effects of a powerful drug when the evidence says it won’t add enough benefit to be worth it.

And for those who do need it, the test offers something else: confidence. If your result points to chemotherapy, you’re not taking the Red Devil on a hunch. You’re taking it because your tumor’s own biology said it would help.

Either answer is a gift. One spares you a hard treatment you don’t need. The other gives you a clear reason to trust a hard treatment you do.

Why the Red Devil Affects Hair — and Why That’s Connected

In the same discussion, the conversation turned to why this drug causes the side effects it does — and the answer ties back to how it fights cancer.

The Red Devil targets rapidly dividing cells. As Dr. Singh confirmed, “skin and hair are rapidly dividing cells, and so those are affected.”

Cancer cells divide quickly — that’s what makes them cancer. But hair follicles and skin cells divide quickly too, so they get caught in the same net. It’s the very mechanism that makes the drug effective against fast-growing cancer that also makes it hard on your hair.

Understanding that link can make the side effects feel less random. They’re not the drug misbehaving — they’re the flip side of the drug working. (We cover hair loss and how cold capping can help, in a dedicated post in this series.)

Questions Worth Asking Your Oncologist

If you’re facing the chemo decision, genomic testing is worth raising directly. A few questions that help:

• “Is my cancer a candidate for genomic testing like Oncotype or MammaPrint?” Not every cancer type qualifies, so it’s worth asking.
• “What would my result tell us about whether I need chemotherapy?”
• “If I’m high-risk, would that include the Red Devil?”
• “If I’m low-risk, could I safely avoid chemo?”

These aren’t challenging questions — they’re exactly the kind a good oncologist wants you to ask. The more you understand why a treatment is or isn’t recommended, the more steady you’ll feel in the decision.

Frequently Asked Questions

Q1. Can genomic testing tell me if I need the Red Devil?
A: It can help. Dr. Singh explains that a high-risk result on tests like Oncotype DX or MammaPrint suggests chemotherapy would benefit you — and that chemotherapy may include the Red Devil.

Q2. What’s the difference between genomic and genetic testing?
A: Genetic testing looks at inherited genes that affect your cancer risk (like BRCA). Genomic testing looks at the tumor itself to predict how it will behave and whether chemotherapy will help.

Q3. What are Oncotype DX and MammaPrint?
A: They’re genomic tests that analyze the genes active in your tumor and turn that into a recurrence-risk score, helping guide whether chemotherapy is likely to benefit you.

Q4. Could genomic testing mean I avoid chemo altogether?
A: For some women, yes. A low-risk result may mean chemotherapy adds little benefit and can be safely skipped. Your oncologist interprets the result alongside your full situation.

Q5. Why does the Red Devil cause hair loss?
A: It targets rapidly dividing cells. Cancer cells divide fast, but so do hair and skin cells, so they’re affected too. It’s the same mechanism that makes the drug effective against cancer.

Knowledge Makes the Decision Easier

Facing a chemotherapy decision is one of the hardest moments in breast cancer. The more you understand the tools that guide it, the less alone you feel in it.

Learn about your tumor: Our genomic testing guide explains how testing reads your cancer’s behavior to guide treatment.

Start here: Our full Red Devil Chemotherapy guide walks through how the drug works, who receives it, and how every side effect is managed.

You don’t walk this alone.

Part of Learn Look Locate’s Red Devil chemotherapy series, drawn from our discussion with Dr. Rahul Singh, Medical Oncologist and LLL Medical Advisor, and medically reviewed by Dr. Singh.

Watch Dr. Singh: How Genomic Testing Determines If You Need Red Devil Chemotherapy How Genomic Testing Determines If You Need Red Devil Chemotherapy